Objectives

After participating in this educational activity, attendees should be able to:
1| Describe the updated nomenclature of steatotic liver disease 
2| Identify patients with risk factors for MASLD
3| Evaluate current and emerging therapeutic strategies for MASLD
4| Discuss the role of Primary Care Physicians and Endocrinologist in the management of MASLD

Presenter(s): 

Yousaf Shaikh, MD
Fellow, Division of Endocrinology, Diabetes & Metabolism
Division of Endocrinology and Diabetes

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Yousaf Shaikh, MD SpeakerNo relevant relationships with ineligible companies to discloseNo

 

Session date: 
05/06/2025 - 12:00pm to 1:00pm EDT
Location: 
Webinar
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 IPCE Credit Hour(s)

Please login or register to take this course.